Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Breast Neoplasms × Resistance Training × Clear all

Phase

Status

Completed 10 Active not recruiting 3 Recruiting 2 Withdrawn 1 Unknown 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 1 Muscular Diseases 1 Motor Activity 1 Cachexia 1 Breast Neoplasms 1

Interventions

Paclitaxel 20 Trastuzumab 17 Docetaxel 13 Cyclophosphamide 13 Capecitabine 10 Letrozole 9 Doxorubicin 9 exemestane 8 Radiotherapy 8 Fulvestrant 8 Lapatinib 7 Carboplatin 7 pembrolizumab 6 Goserelin 6 Anastrozole 6 palbociclib 5 eribulin 5 Therapeutics 5 Neoadjuvant Therapy 5 Chemotherapy, Adjuvant 5 Bevacizumab 5 Aromatase Inhibitors 5 tucatinib 4 abemaciclib 4 Vinorelbine 4 Taxes 4 Mastectomy, Segmental 4 Magnetic Resonance Spectroscopy 4 Exercise 4 Epirubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04449809 2021-06-21

EXERT-BC

Duke University

Phase NA Withdrawn

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡